PTAB challenges

Proceedings overview

There is one AIA trial proceeding on US Patent 9271536, with a status of Discretionary Denial. This indicates that the patent has not undergone a full inter partes review and its claims have not been substantively challenged and invalidated through the PTAB process. As such, the patent remains hardened against this specific challenge.

IPR2025-01031 — REVELYST SALES LLC et al. v. Robert T. Knight

• Type: Inter Partes Review
• Filed: 2025-07-09
• Status: Discretionary Denial. This means the PTAB declined to institute the inter partes review.
• Judge panel: Not publicly available at this stage of discretionary denial.
• Petition grounds: Information regarding specific claims, prior art, and statutory bases (§ 102 / § 103 / § 112) is not publicly detailed for discretionary denials in the same manner as for instituted trials.
• Institution decision: Denied (Discretionary Denial) — 2025-12-23. The denial was procedural, meaning the PTAB chose not to proceed with the review, likely due to factors such as parallel district court litigation (as suggested by the "Family has litigation" section of the patent).
• Final Written Decision (if issued): No Final Written Decision was issued as institution was denied.
• Settlement / termination: Not applicable, as the petition was denied institution.
• Appeal: Not applicable, as there was no Final Written Decision to appeal.
• Defensive value: The discretionary denial of this IPR means that the claims of US9271536 were not reviewed on their merits in this proceeding. For a defendant facing assertion of this patent, this particular IPR does not weaken the patent's claims. However, it also doesn't preclude future IPR challenges by other parties or the same party on different grounds, assuming no estoppel applies from the denial itself (which is generally less comprehensive than estoppel from a final written decision).

Strategic summary

Currently, all claims of US9271536 are SUSTAINED as they have not been subjected to a full IPR and no claims have been canceled. Specifically, claims 1-20 remain intact. There are no claims that have been narrowed or invalidated through PTAB proceedings.

Regarding the estoppel landscape, since IPR2025-01031 was denied institution on discretionary grounds, the petitioner (REVELYST SALES LLC et al.) and its privies may not be estopped from raising the same grounds in a future IPR petition, depending on the specific reasoning for the discretionary denial. However, the exact scope of estoppel in discretionary denials can be complex and fact-specific. It is generally understood that statutory estoppel under § 315(e)(2) for grounds raised or reasonably could have been raised applies after a final written decision in an IPR, which did not occur here. Therefore, for a defendant currently being asserted against, the prior-art grounds that could have been raised in IPR2025-01031 are still largely available for use in district court litigation or future PTAB challenges by other parties.

As for pattern signals, there has only been one IPR proceeding filed against this patent thus far. The "Not Instituted - Procedural" status and the "Discretionary Denial" outcome suggest the PTAB may have declined to institute based on factors outside the merits of the prior art, possibly due to parallel district court litigation as indicated in the patent's legal status information. There is no clear pattern of aggressive PTAB appeals by the patent owner or multiple IPRs by the same petitioner. The petitioner, REVELYST SALES LLC et al., is listed, but there is no indication of a defensive aggregator like Unified Patents being directly involved in this specific proceeding.

Recommended next steps

Given the discretionary denial of IPR2025-01031, no claims of US9271536 were invalidated. There is no Final Written Decision to link to for claim cancellations.

However, the "Family has litigation" section on the Google Patents page mentions a US case filed in the California Central District Court (case 8:24-cv-02652) and a PTAB case IPR2025-01031. It would be prudent to monitor the ongoing district court litigation for any developments that might affect the patent's validity or claim construction.

If considering a new PTAB challenge, it would be essential to understand the specific reasons for the discretionary denial in IPR2025-01031 to avoid similar procedural pitfalls. Reviewing the PTAB's written decision for the discretionary denial (if available publicly through the USPTO PTAB Decisions portal) would be a critical first step.

Currently, there are no active PTAB trial-stage milestones (institution decision deadline, oral hearing, FWD due date) for IPR2025-01031 because institution was denied. The absence of a successful PTAB challenge means the patent remains robust from an AIA trial perspective.